Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses

Viruses. 2023 Mar 18;15(3):781. doi: 10.3390/v15030781.

Abstract

With the spread of SARS-CoV-2 throughout the globe causing the COVID-19 pandemic, the threat of zoonotic transmissions of coronaviruses (CoV) has become even more evident. As human infections have been caused by alpha- and beta-CoVs, structural characterization and inhibitor design mostly focused on these two genera. However, viruses from the delta and gamma genera also infect mammals and pose a potential zoonotic transmission threat. Here, we determined the inhibitor-bound crystal structures of the main protease (Mpro) from the delta-CoV porcine HKU15 and gamma-CoV SW1 from the beluga whale. A comparison with the apo structure of SW1 Mpro, which is also presented here, enabled the identification of structural arrangements upon inhibitor binding at the active site. The cocrystal structures reveal binding modes and interactions of two covalent inhibitors, PF-00835231 (active form of lufotrelvir) bound to HKU15, and GC376 bound to SW1 Mpro. These structures may be leveraged to target diverse coronaviruses and toward the structure-based design of pan-CoV inhibitors.

Keywords: GC376; HKU15; beluga whale; coronaviruses; crystal structure; direct-acting antivirals; drug design; gammacoronavirus; lufotrelvir; main protease; pan-coronavirus inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • COVID-19*
  • Humans
  • Mammals
  • Pandemics
  • Peptide Hydrolases / metabolism
  • Protease Inhibitors / chemistry
  • SARS-CoV-2 / metabolism
  • Swine

Substances

  • Antiviral Agents
  • Peptide Hydrolases
  • Protease Inhibitors

Grants and funding

This research received no external funding. The research at the CAS laboratory was funded by Novartis Institutes for Biomedical Research.